Want to see UCLE full AI Analyst Report?
Top Page
US Nuclear
(OTC:UCLE)
Select Model
Select Model
Rating:43Neutral
Price Target:
$0.01
▼(-30.00% Downside)
Action:Reiterated
Date:09/30/26
The score is primarily held down by weak financial performance (ongoing losses, negative free cash flow, and negative equity) and bearish technical signals (below major moving averages with negative MACD). Some operational improvement (better margins, narrower losses, and reduced cash burn/debt) provides modest support, but valuation metrics offer limited help given the negative P/E and no dividend yield.
Positive Factors
Improved gross margin
The stronger 2025 gross margin indicates improved product economics and potentially better cost control. If maintained, higher gross profit per sale could support reinvestment, reduce operating losses, and improve the company’s ability to approach sustainable profitability over coming quarters.
Negative Factors
Negative shareholders’ equity
A multi-year negative equity position reflects accumulated losses and leaves the company with limited balance-sheet flexibility. This weak capital base reduces its cushion against setbacks and can constrain future investment, financing options, and resilience while losses continue.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved gross margin
The stronger 2025 gross margin indicates improved product economics and potentially better cost control. If maintained, higher gross profit per sale could support reinvestment, reduce operating losses, and improve the company’s ability to approach sustainable profitability over coming quarters.
Read all positive factors
US Nuclear (UCLE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$973.75K
Dividend YieldN/A
Average Volume (3M)14.27K
Price to Earnings (P/E)―
Beta (1Y)0.88
Revenue Growth-0.98%
EPS Growth33.93%
CountryUS
Employees8
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)N/A
Shares Outstanding62,822,260
10 Day Avg. Volume15,715
30 Day Avg. Volume14,265
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-3.59
Price to Sales (P/S)0.85
P/FCF Ratio-9.25
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
US Nuclear Business Overview & Revenue Model
Company Description
US Nuclear Corp. (UCLE) is a global entity dedicated to the engineering, production, and sale of advanced radiation detection and measurement technologies. The company conducts its operations through two primary divisions: Optron and Overhoff. Its...
How the Company Makes Money
U.S. Nuclear generates revenue primarily by selling radiation detection and measurement products (hardware) and related systems/accessories to customers needing radiological monitoring and safety capabilities. To the extent offered, the company ma...
US Nuclear Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.17M | 2.19M | 2.23M | 2.09M | 2.14M |
| Gross Profit | 1.09M | 1.02M | 924.31K | 788.07K | 1.38M |
| EBITDA | -1.40M | -1.51M | -1.78M | -1.49M | -1.81M |
| Net Income | -1.24M | -1.74M | -3.43M | -2.04M | -1.88M |
Balance Sheet | |||||
| Total Assets | 1.92M | 2.65M | 2.86M | 3.11M | 2.85M |
| Cash, Cash Equivalents and Short-Term Investments | 134.78K | 130.84K | 152.84K | 126.11K | 246.32K |
| Total Debt | 916.32K | 1.78M | 2.24M | 1.60M | 910.27K |
| Total Liabilities | 2.44M | 3.50M | 4.84M | 3.46M | 2.41M |
| Stockholders Equity | -513.69K | -856.16K | -1.98M | -348.30K | 441.27K |
Cash Flow | |||||
| Free Cash Flow | -199.34K | -509.05K | -264.30K | -1.32M | -447.47K |
| Operating Cash Flow | -199.34K | -509.05K | -263.44K | -1.32M | -441.03K |
| Investing Cash Flow | 0.00 | -30.77K | -24.55K | 0.00 | -21.45K |
| Financing Cash Flow | 203.28K | 517.82K | 314.72K | 1.20M | 481.49K |
US Nuclear Technical Analysis
Negative
0.02
Price Trends
0.03
Negative
0.03
Negative
0.05
Negative
Market Momentum
>-0.01
Negative
37.38
Neutral
37.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UCLE, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 37.38 is Neutral, neither overbought nor oversold. The STOCH value of 37.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UCLE.
US Nuclear Risk Analysis
US Nuclear disclosed 33 risk factors in its most recent earnings report. US Nuclear reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
US Nuclear Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $86.40M | -343.00 | -0.53% | ― | 26.35% | -130.90% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | $15.10M | 1.83 | 34.15% | ― | -21.65% | ― | |
47 Neutral | $71.74M | 813.04 | 0.15% | ― | 25.56% | ― | |
46 Neutral | $39.31M | -16.95 | -5.77% | 1.53% | -28.46% | -147.43% | |
43 Neutral | $973.75K | -0.60 | 275.26% | ― | -0.98% | 33.93% |
* Technology Sector Average
UCLE
US Nuclear
0.02
-0.01
-44.44%
LGL
LGL Group
6.86
0.11
1.63%
MIND
MIND Technology
4.45
-3.89
-46.64%
NEON
Neonode
0.89
-2.54
-73.94%
CPSH
CPS Technologies
3.74
0.17
4.76%
IMTE
Integrated Media Technology
0.45
-0.79
-63.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.